Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Dr. Allison Betof Warner from Stanford University joins Rahul Gosain, MD and Rohit Gosain, MD, on the Oncology Brothers podcast to discuss melanoma treatment. The conversation covers the…
NEW YORK (Reuters Health) – High blood pressure accounts for some of the disproportionately higher mortality rates among African American patients with breast cancer compared with Caucasian patients,…
NEW YORK (Reuters Health) – An analysis of data from the Health Professionals Follow-up Study confirms that men with diabetes mellitus are less prone to develop prostate cancer…
NEW YORK (Reuters Health) – When radical cystectomy is not performed within 12 weeks of diagnosis with stage II bladder cancer, all-cause and disease-specific mortality increases, US researchers…
Jaime Landman MD, Director of Minimally Invasive Urology at Columbia Medical Center discusses Cytoreductive Nephrectomy, the cutting edge of kidney cancer management for patients whose disease is not…
NEW YORK (Reuters Health) – Men ages 75 to 80 years old with a prostate specific antigen (PSA) level less than 3 ng/mL are unlikely to experience life-threatening…
NEW YORK (Reuters Health) – In older prostate cancer patients with a biochemical recurrence, cancer anxiety predicts earlier use of androgen deprivation therapy (ADT), new research shows. This…
NEW YORK (Reuters Health) – New evidence indicates that elevated serum levels of ionized calcium may predict the risk of death from prostate cancer. If verified in future…
NEW YORK (Reuters Health) – In a phase I trial involving patients with advanced squamous cell carcinoma of the head and neck (SCCHN), direct intratumoral injection of epithelial…
NEW YORK (Reuters Health) – Patients with rectal cancer whose disease is downstaged with neoadjuvant radiation therapy have better survival than their peers who fail to respond to…
NEW YORK (Reuters Health) – Yearly gynecological examinations fail to identify early stage ovarian cancer in women with a mutation in the BRCA1 or BRCA2 gene, a Dutch…
